Tumor microenvironment modulation via paracrine signaling from encapsulated tumor cells

The entry "Tumor microenvironment modulation via paracrine signaling from encapsulated tumor cells" does not refer to a single canonical molecular target but rather describes a complex biological process. In cancer biology, paracrine signaling refers to communication where tumor cells secrete soluble factors—such as cytokines, growth factors, glycoproteins like thrombospondin 1 (THBS1), and metabolites—that act on neighboring non-malignant stromal or immune cells within the tumor microenvironment. This crosstalk can promote cancer cell proliferation, induce stemness features in surrounding epithelial or stromal cells through pathways like YAP activation, modulate immune responses and chemoresistance through cytokines such as interleukin 6 (IL‑6), and generally support an environment conducive to tumor progression and therapy resistance. Because this is not an individual protein/receptor/enzyme but instead describes an entire class of interactions/processes involving multiple molecules and cell types—including fibroblasts, mesenchymal stem cells, endothelial cells, immune infiltrates—the term is too broad for use as a canonical therapeutic target. Instead, research focuses on identifying key mediators within these networks for drug development—for example: “We identify the glycoprotein thrombospondin 1 (THBS1) as the essential factor that mediates non-cell-autonomous morphological and transcriptional responses… This study reveals the THBS1-YAP axis as the mechanistic link mediating paracrine interactions between epithelial cells in intestinal tumours.” Similarly, “CAFs are proficient in paracrine signaling… Among the most extensively studied pro-stemness cytokines secreted by CAFs are IL‑6 and IL‑8…” Thus, Tumor microenvironment modulation via paracrine signaling from encapsulated tumor cells is not itself a druggable molecular target, but rather encompasses many potential targets within its network. If you need structured information about specific molecules involved—such as "Thrombospondin 1", "Interleukin 6", etc.—please specify those entities individually.

Other names

Paracrine signaling in the tumor microenvironmentTumor cell paracrine modulationParacrine-mediated tumor-stroma interaction

Not applicable to this entry; mechanisms would depend on the specific paracrine factor targeted, e.g., anti–IL‑6 antibodies block IL‑6 mediated effects